E
Immutep Limited
IMMP
$1.75
$0.052.94%
E
Sell
7/29/2024Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 7/29/2024 due to a decline in the volatility index and total return index.
Immutep Limited (IMMP) was downgraded to E+ from D- on 7/29/2024 due to a decline in the volatility index and total return index.
D
Sell
7/12/2024Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 7/12/2024 due to an increase in the volatility index and valuation index.
Immutep Limited (IMMP) was upgraded to D- from E+ on 7/12/2024 due to an increase in the volatility index and valuation index.
E
Sell
6/27/2024Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 6/27/2024 due to a decline in the volatility index.
Immutep Limited (IMMP) was downgraded to E+ from D- on 6/27/2024 due to a decline in the volatility index.
D
Sell
5/17/2024Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 5/17/2024 due to an increase in the total return index and volatility index.
Immutep Limited (IMMP) was upgraded to D- from E+ on 5/17/2024 due to an increase in the total return index and volatility index.
E
Sell
3/28/2024Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 3/28/2024 due to a decline in the volatility index.
Immutep Limited (IMMP) was downgraded to E+ from D- on 3/28/2024 due to a decline in the volatility index.
D
Sell
3/6/2024Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 3/6/2024 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0059 to -$0.0058, EBIT increased 0.48% from -$7.57M to -$7.54M, and operating cash flow increased 0.47% from -$6.04M to -$6.01M.
Immutep Limited (IMMP) was upgraded to D- from E+ on 3/6/2024 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0059 to -$0.0058, EBIT increased 0.48% from -$7.57M to -$7.54M, and operating cash flow increased 0.47% from -$6.04M to -$6.01M.
E
Sell
2/26/2024Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 2/26/2024 due to a decline in the volatility index.
Immutep Limited (IMMP) was downgraded to E+ from D- on 2/26/2024 due to a decline in the volatility index.
D
Sell
2/9/2024Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index, total return index and valuation index.
Immutep Limited (IMMP) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
1/25/2024Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 1/25/2024 due to a decline in the volatility index.
Immutep Limited (IMMP) was downgraded to E+ from D- on 1/25/2024 due to a decline in the volatility index.
D
Sell
1/10/2024Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 1/10/2024 due to an increase in the total return index and volatility index.
Immutep Limited (IMMP) was upgraded to D- from E+ on 1/10/2024 due to an increase in the total return index and volatility index.
E
Sell
9/20/2023Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 9/20/2023 due to a decline in the growth index, total return index and volatility index. Total revenue declined 2.27% from $622 to $607.9.
Immutep Limited (IMMP) was downgraded to E+ from D- on 9/20/2023 due to a decline in the growth index, total return index and volatility index. Total revenue declined 2.27% from $622 to $607.9.
D
Sell
8/4/2023Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 8/4/2023 due to an increase in the valuation index.
Immutep Limited (IMMP) was upgraded to D- from E+ on 8/4/2023 due to an increase in the valuation index.
E
Sell
7/20/2023Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D- on 7/20/2023 due to a decline in the valuation index.
Immutep Limited (IMMP) was downgraded to E+ from D- on 7/20/2023 due to a decline in the valuation index.
D
Sell
6/29/2023Upgraded
Immutep Limited (IMMP) was upgraded to D- from E+ on 6/29/2023 due to a noticeable increase in the total return index and volatility index.
Immutep Limited (IMMP) was upgraded to D- from E+ on 6/29/2023 due to a noticeable increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the growth index, total return index and solvency index. Total revenue declined 3.83% from $725.3 to $697.5.
Immutep Limited (IMMP) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the growth index, total return index and solvency index. Total revenue declined 3.83% from $725.3 to $697.5.
D
Sell
2/9/2023Upgraded
Immutep Limited (IMMP) was upgraded to D from E+ on 02/09/2023.
Immutep Limited (IMMP) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the total return index, solvency index and volatility index.
Immutep Limited (IMMP) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the total return index, solvency index and volatility index.
D
Sell
5/16/2022Upgraded
Immutep Limited (IMMP) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Immutep Limited (IMMP) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
Immutep Limited (IMMP) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
Immutep Limited (IMMP) was upgraded to D from E+ on 05/04/2022.
Immutep Limited (IMMP) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D on 05/01/2022.
Immutep Limited (IMMP) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
Immutep Limited (IMMP) was upgraded to D from E+ on 4/21/2022 due to an increase in the valuation index.
Immutep Limited (IMMP) was upgraded to D from E+ on 4/21/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index and volatility index.
Immutep Limited (IMMP) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell
11/9/2021Upgraded
Immutep Limited (IMMP) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
Immutep Limited (IMMP) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
E
Sell
11/8/2021Downgrade
Immutep Limited (IMMP) was downgraded to E+ from D on 11/8/2021 due to a substantial decline in the growth index, efficiency index and volatility index. Total capital declined 1.49% from $57.91M to $57.05M, and total revenue declined 0.36% from $637.7 to $635.4.
Immutep Limited (IMMP) was downgraded to E+ from D on 11/8/2021 due to a substantial decline in the growth index, efficiency index and volatility index. Total capital declined 1.49% from $57.91M to $57.05M, and total revenue declined 0.36% from $637.7 to $635.4.
D
Sell
2/21/2020Upgraded
Immutep Limited (IMMP) was upgraded to D from D- on 2/21/2020 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 0.31% from -$1.78M to -$1.78M, and EBIT increased 0.31% from -$2.18M to -$2.17M.
Immutep Limited (IMMP) was upgraded to D from D- on 2/21/2020 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 0.31% from -$1.78M to -$1.78M, and EBIT increased 0.31% from -$2.18M to -$2.17M.
D
Sell
6/11/2019Downgrade
Immutep Limited (IMMP) was downgraded to D- from D on 6/11/2019 due to a large decline in the solvency index, total return index and growth index.
Immutep Limited (IMMP) was downgraded to D- from D on 6/11/2019 due to a large decline in the solvency index, total return index and growth index.
D
Sell
2/28/2019Upgraded
Immutep Limited (IMMP) was upgraded to D from D- on 2/28/2019 due to a large increase in the solvency index, total return index and volatility index.
Immutep Limited (IMMP) was upgraded to D from D- on 2/28/2019 due to a large increase in the solvency index, total return index and volatility index.
D
Sell
7/24/2017Downgrade
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 7/24/2017 due to a decline in the volatility index and total return index.
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 7/24/2017 due to a decline in the volatility index and total return index.
D
Sell
7/7/2017Upgraded
Prima Biomed Ltd. (PBMD) was upgraded to D from D- on 7/7/2017 due to an increase in the growth index, total return index and efficiency index. Total revenue increased 117.07% from $596.3 to $1.29M, and EBIT increased 12.14% from -$1.54M to -$1.35M.
Prima Biomed Ltd. (PBMD) was upgraded to D from D- on 7/7/2017 due to an increase in the growth index, total return index and efficiency index. Total revenue increased 117.07% from $596.3 to $1.29M, and EBIT increased 12.14% from -$1.54M to -$1.35M.
D
Sell
2/24/2017Upgraded
Prima Biomed Ltd. (PBMD) was upgraded to D- from E+ on 2/24/2017 due to a large increase in the solvency index, growth index and efficiency index. Operating cash flow increased 1.18% from -$1.56M to -$1.54M, EBIT increased 1.18% from -$1.53M to -$1.51M, and net income increased 1.18% from -$1.54M to -$1.52M.
Prima Biomed Ltd. (PBMD) was upgraded to D- from E+ on 2/24/2017 due to a large increase in the solvency index, growth index and efficiency index. Operating cash flow increased 1.18% from -$1.56M to -$1.54M, EBIT increased 1.18% from -$1.53M to -$1.51M, and net income increased 1.18% from -$1.54M to -$1.52M.
E
Sell
1/10/2017Downgrade
Prima Biomed Ltd. (PBMD) was downgraded to E+ from D- on 1/10/2017 due to a noticeable decline in the valuation index, volatility index and total return index.
Prima Biomed Ltd. (PBMD) was downgraded to E+ from D- on 1/10/2017 due to a noticeable decline in the valuation index, volatility index and total return index.
D
Sell
10/4/2016Downgrade
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 10/4/2016 due to a decline in the volatility index and total return index.
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 10/4/2016 due to a decline in the volatility index and total return index.
D
Sell
9/19/2016Upgraded
Prima Biomed Ltd. (PBMD) was upgraded to D from D- on 9/19/2016 due to a noticeable increase in the volatility index, growth index and efficiency index. Total revenue increased 3.27% from $180.7 to $186.6.
Prima Biomed Ltd. (PBMD) was upgraded to D from D- on 9/19/2016 due to a noticeable increase in the volatility index, growth index and efficiency index. Total revenue increased 3.27% from $180.7 to $186.6.
D
Sell
3/11/2016Downgrade
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 3/11/2016 due to a significant decline in the growth index, volatility index and solvency index. Total revenue declined 0.76% from $458.8 to $455.3.
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 3/11/2016 due to a significant decline in the growth index, volatility index and solvency index. Total revenue declined 0.76% from $458.8 to $455.3.
D
Sell
7/14/2014Upgraded
Prima Biomed Ltd. (PBMD) was upgraded to D from D- on 7/14/2014 due to an increase in the volatility index and total return index.
Prima Biomed Ltd. (PBMD) was upgraded to D from D- on 7/14/2014 due to an increase in the volatility index and total return index.
D
Sell
4/22/2014Downgrade
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 4/22/2014 due to a decline in the valuation index, solvency index and efficiency index. Total capital declined 4.32% from $28.05M to $26.83M.
Prima Biomed Ltd. (PBMD) was downgraded to D- from D on 4/22/2014 due to a decline in the valuation index, solvency index and efficiency index. Total capital declined 4.32% from $28.05M to $26.83M.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
